Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
about
Allergen injection immunotherapy for seasonal allergic rhinitisImmune mechanisms of allergen-specific sublingual immunotherapy.Cytokine expression in allergic inflammation: systematic review of in vivo challenge studiesMouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine.Sublingual immunotherapy for allergic rhinoconjunctivitis--the seeming and the real.Immunotherapy of hypersensitivity to hymenoptera venom.IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy.Sublingual immunotherapy of allergic diseases.Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge.Protocol for a double-blind randomised controlled trial of low dose intradermal grass pollen immunotherapy versus a histamine control on symptoms and medication use in adults with seasonal allergic rhinitis (PollenLITE).T-cell responses induced by allergen-specific immunotherapy.Immunotherapy in asthma.Specific immunotherapy in children: the evidence.Cytokine profiles in allergic rhinitis.Pathogenesis of rhinitis.Novel approaches and perspectives in allergen immunotherapy.Defining the T cell antigen proteome of wasp venom.Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy.Allergen immunotherapy decreases LPS-induced NF-κB activation in neutrophils from allergic patients.Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.Nasal treatment with a microemulsion reduces allergen challenge-induced symptoms and signs of allergic rhinitis.Increased expression of allergen-induced in vitro interleukin-10 and interleukin-18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapy.Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios.Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.Efficacy of pollen immunotherapy in seasonal allergic rhinitis.Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.The future outlook on allergen immunotherapy in children: 2018 and beyond.
P2860
Q24243115-C4398181-5402-4293-B6C9-D2945EE77A04Q34484071-7EE8DE07-FAB7-4DB9-AB3A-86F0D96AB536Q35648173-1F8C2CC5-8294-4D3D-9DFA-407E13D9126CQ35949214-ADB3834F-5C0E-440D-B4BE-40CEBEEB1C55Q36157889-67AAFA99-272B-4B9C-9B33-ACE3DF5988A9Q36273406-6D36D04C-54F9-464C-8D4F-A74DF8CC976BQ36545702-1054F3E6-5178-4B9C-A53D-DCAA5BF7A9C2Q36583727-82E84D4B-E1F1-4F90-9642-6504221D3858Q36784749-D9FF9EF3-1872-47AF-876B-B8888BCAE8F2Q37153212-B75B526C-1DE7-4EB1-97C6-A0B3DBC3F230Q37735267-9ED80168-5025-46FC-A7A6-688D04EE7414Q37793242-BF95FC02-257C-4256-AC5D-0CA8B0A76F91Q37950136-E54A66B1-8B59-42A1-8B24-5EF4E372CF1BQ38196334-CCDF1D08-FD2A-450F-A795-B8534548FB55Q38902173-2771F6F8-4AD2-4A3D-9939-269FC73D3A1DQ39103046-F370AB9E-0C7D-43FE-83FF-4549832EFED4Q40282948-6BB3B28B-7AB7-42D5-AB1B-A3BC1B577229Q42153928-44692A3B-1251-4CE9-9C03-2AD59E397699Q43690408-F0248CF7-11AD-445A-86F1-FABE5ECD19B0Q46714664-1CADA8A7-7FEE-423F-A3C5-7A8A33E37334Q47623922-7C9FBD2F-6023-440A-8D21-978697F57C16Q47988502-C87B8F1A-51A7-492C-BE86-20092FE89124Q51727137-E2FFE5F5-0F31-4596-AD0D-2EA103FF96E9Q52940754-91ED8E52-C9E4-4E3E-A505-CEFAA59D8A69Q53575340-BD5CBC6B-2A11-44A7-B00C-2CEAC09F6F17Q54584880-2BBD3694-8BF7-432D-A5BF-1AE3A5CB624BQ55662210-FECCB65E-218E-4728-B22A-5CA30A7A0052
P2860
Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Grass pollen immunotherapy: sy ...... cosa during the pollen season.
@en
type
label
Grass pollen immunotherapy: sy ...... cosa during the pollen season.
@en
prefLabel
Grass pollen immunotherapy: sy ...... cosa during the pollen season.
@en
P2093
P356
P1476
Grass pollen immunotherapy: sy ...... ucosa during the pollen season
@en
P2093
P304
P356
10.1067/MAI.2001.115483
P407
P577
2001-06-01T00:00:00Z